Abstract
We developed a simple, rapid and efficient microwave irradiation-assisted protocol that is 1- to 2-orders of magnitude faster than conventional techniques, providing an expedient access to the sialic acid congeners Neu5Ac1Me (1), Neu5Acβ1,2Me2 (2), Neu5Ac1Me O-peracetate (3) and 4,5-oxazoline of Neu5Ac2en1Me O-peracetate (4).
N-acetylneuraminic acid (sialic acid; Neu5Ac) is a sugar amino acid found as the terminal monosaccharide of many glycoconjugates on mammalian cell surfaces. It plays a crucial role in vital biological processes as a mediator of intercellular communication and adhesion, viral receptor recognition, and various (patho)physiological processes.1, 2 Thus, many efforts have been devoted to the design and synthesis of Neu5Ac congeners as chemical probes3 and antiviral agents.2, 4 For example, von Itzstein developed the neuraminidase inhibitor zanamivir4 (4-guanidino-Neu5Ac2en, 5) from Neu5Ac that is being stockpiled around the world to combat potential influenza pandemic. However, neuraminidase inhibitor drug resistance is emerging, which has sparked renewed interest in sialic acid analogues. Recently, Withers and co-workers reported that 2,3-difluoro-4-guanidino-Neu5Ac (6) is active against zanamivir-resistant influenza virus strains,5 demonstrating the importance of the chemistry of functionalized sialic acid.
The key intermediate in the preparation of 5, 6 and other related C-4 substituted congeners of Neu5Ac2en (7) is the peracetylated 4-azido-2-deoxy-2,3-dehydro-N-acetylneuraminic acid methyl ester (8). Compound 8 can be conveniently prepared from the 4,5-oxazoline derivative of O-peracetylated Neu5Ac2en (4) via SN2 type azidation and oxazoline ring opening upon treatment with TMSN3 or LiN3.6 The oxazoline is easily synthesized through Lewis acid-promoted intramolecular β-attack of the 5-acetamido group on the adjacent allylic C-4 position of the glycal. The two common methods to prepare 4 are: (a) treatment of 3 with trimethylsilyl trifluoromethanesulfonate (TMSOTf)7, 8 and (b) treatment of Neu5Ac2en1Me O-peracetate (9) with SnCl4 or BF3.Et2O.9 Although these reactions are efficient and are complete within 2 – 16 h (Scheme 1a), synthesis of their precursors 3 and 9 are traditionally more cumbersome. The synthesis of 3 requires esterification and peracetylation, which can then undergo elimination to give the glycal 9 using TMSOTf or BF3.Et2O (Scheme 1a). Standard C-1 esterification can be performed using the highly reactive but toxic and explosive CH2N2 or by Fischer esterification using MeOH and catalytic trifluoroacetic acid (TFA) or dry Dowex 50×8 (H+) resin, requiring 24 – 48 h to yield Neu5Ac1Me (1). Neu5Ac peracetylation is typically accomplished using excess Ac2O and pyridine at ambient conditions for ~20 h to generate Neu5Ac1Me O-peracetate (3).8, 10-13 Although these have very slow reaction kinetics, they are still the current methods of choice.
Scheme 1.
(a) Conventional synthesis and (b) optimized microwave irradiation-assisted synthesis of Neu5Ac congeners.
We successfully demonstrated the utility of Neu5Ac derivatives as useful building blocks for solid phase synthesis of amide-linked oligomers with stable secondary structures and remarkable proteolytic stability.12, 14 As part of our continuing studies on unnatural Neu5Ac peptides, we employed the standard methods described above to prepare Neu5Ac congeners, but found these to be too sluggish. Recently, there has been an increasing interest in microwave energy-assisted heating to drive chemical reactions. Among other advantages, microwave heating dramatically reduces reaction times from days or hours to minutes, allowing rapid access to target molecules.15 Despite these benefits, microwave-assisted synthesis remains underutilized for the chemical manipulations of sialic acid.16, 17, 18 In order to expedite the synthesis of Neu5Ac congeners, we examined the effect of microwave irradiation to accelerate these chemical transformations. Herein we report a microwave-assisted protocol for the gram-scale preparation of 1, 2, 3 and 4, at reaction rates that are 1- to 2-orders of magnitude faster than conventional techniques.
Since Neu5Ac1Me 1 is the most common synthetic derivative of Neu5Ac, we started the optimization of its synthesis by modifying the method described by Schauer.13 Initial screening was carried out by treating Neu5Ac (0.20 g, 0.65 mmol) with catalytic TFA in anhydrous MeOH. We used the Biotage Initiator SP Wave synthesizer and set the microwave-assisted heating at 80 °C with variable power for various times (Scheme 1b). The reaction progress was monitored by thin layer chromatography, which indicated that Neu5Ac was completely consumed after 30 and 50 min at 80 °C by using 0.4 and 0.2 equiv of TFA, respectively (see Supplementary Information). Investigation by electrospray ionization mass spectrometry (ESI-MS) indicated that the major product (90 – 95%) formed for both treatments was 1 (m/z 346.1, [M+Na]+). 1H NMR analysis showed a broad singlet at δ 3.82 corresponding to the OMe peak of the C-1 methyl ester and a doublet of doublets at δ 2.29 (H-3eq, J = 13.0, 4.9 Hz). We noticed a minor product with m/z 360.2 ([M+Na]+; Δm/z from 1 = 14.1) indicating methylation of C-2 OH to form the methyl sialoside Neu5Acβ1,2Me2 2 (See supplementary information). This can be expected since 2 has been previously prepared using MeOH/H+ under ambient11 and microwave conditions.16
To investigate if irradiation at higher temperatures would favor the formation of 1 within 30 min, we treated Neu5Ac with 0.4 equiv TFA at varying temperatures (80 – 120 °C at 10 degree increments, Table 1). It was interesting that the reaction mixture yielded higher amounts of 2 at higher temperatures. This observation also correlated well to the increase in 1H NMR resonance intensity of the H-3eq of 2 (δ 2.35, dd, J = 13.5, 4.9 Hz) that confirms its increased formation with temperature, reaching a ratio of 1:1 at 120 °C based on resonance peak area integration (Figure 2). The above finding seemed to offer a handle for directing the formation of 2. Further irradiation to higher temperatures resulted in the formation of compound 2, and concurrently, other uncharacterized products (Figure 2 and Supplementary Information). Since our interest is to prepare the methyl ester 1 in large amounts, we proceeded with the optimization, maintaining the conditions at 80 °C for 30 min using 1 g of Neu5Ac. At this point we found it necessary to dilute the reaction mixture to 20 mL (0.16 M Neu5Ac in MeOH) to produce 1 as the sole product (Table 2 and Supplementary Information) at quantitative isolated yield. A previous report on an efficient microwave-assisted synthesis of 1 used Dowex 50×8 (H+) as catalyst.16 However, it was noted that resin age and quality influence the outcomes of the reaction, requiring tedious resin conditioning followed by storage in inert conditions. The use of TFA as described in our present work offers an economical and simple alternative towards consistent and reproducible preparation of Neu5Ac1Me.
Table 1.
Optimization of microwave-assisted synthesis of 1 at 30 min using variable temperatures.
| Entry | Temperature (°C) | Ratio (1:2) |
|---|---|---|
| 1 | 80 | 1.00 : 0.05 |
| 2 | 90 | 1.00 : 0.23 |
| 3 | 100 | 1.00 : 0.27 |
| 4 | 110 | 1.00 : 0.55 |
| 5 | 120 | 1.00 : 1.00 |
Reactions were carried out using 200 mg of Neu5Ac (0.65 mmol) and 0.4 equiv. of TFA in anhydrous MeOH (3 mL). Ratios were measured by integrating the H-3eq resonance peak of products in 1H-NMR (500 MHz, D2O, 298 K). Neu5Ac1Me (1): δ 2.30 (dd, J3eq, 3ax 13.1, J3eq, 4 4.9 Hz) Neu5Acβ1,2Me2 (2): 2.35 (dd, 1H, J3eq, 3ax 13.1, J3eq, 4 5.0 Hz).
Figure 2.
1H NMR spectra of crude esterification reaction mixtures showing increasing amounts of 2 at higher temperatures (500 MHz, D2O).
Table 2.
Optimization of the scale-up synthesis of 1.
| Entry | MeOH (mL) | Ratio (1:2) |
|---|---|---|
| 1 | 8 | 1.0 : 0.1 |
| 2 | 9 | 1.0 : 0.2 |
| 3 | 10 | 1.0 : 0.1 |
| 4 | 11 | 1.0 : 0.2 |
| 5 | 12 | 1.0 : 0.2 |
| 6 | 15 | 1.0 : 0.1 |
| 7 | 20 | 1.0 : 0.0 |
Reactions were carried out using 1.0 g of Neu5Ac (3.23 mmol) and 0.4 equiv. of TFA in anhydrous MeOH. The mixture was microwave irradiated to 80 °C for 30 min. Ratios were measured by integrating the H-3eq resonance peak of products in 1H-NMR (500 MHz, D2O, 298 K). Neu5Ac1Me (1): δ 2.30 (dd, J3eq, 3ax 13.1 Hz, J3eq, 4 4.9 Hz) Neu5Acβ1,2Me2 (2): 2.35 (dd, 1H, J3eq, 3ax 13.1 Hz, J3eq, 4 5.0 Hz).
The standard method of peracetylating carbohydrates uses excess Ac2O in pyridine at room temperature. We examined the effect of microwave irradiation on the synthesis of Neu5Ac1Me O-peracetate 3 by treating 1 with Ac2O (25 equiv), pyridine (30 equiv), and N,N-dimethylaminopyridine (DMAP, 5 mol %) and irradiating the mixture to 40 °C which went to completion at 45 min. Noting the mild temperature compared to the esterification conditions used in microwave-assisted reactions, we dramatically increased the temperature to 90 °C with the expectation that the kinetics of this thermally driven reaction would benefit from further heating. We found 1 consumed within 10 min but this also occurred with concomitant partial decomposition of the starting material. We investigated irradiation conditions at 50, 60, 70, 80 °C at 10 min and found 70° C to be optimal, leading to clean formation of 3 (Supplementary Information). These conditions were translated to a larger scale (1.0 g) giving 93% isolated yield of 3.
Despite the efficiency of the optimized microwave-assisted peracetylation as described above, it is still desirable to avoid the use of hazardous and noxious reagents like pyridine when possible as well as avoid solvent intensive and laborious column chromatographic purification which restrict our method's general utility. To overcome these limitations, we investigated a more benign peracetylation method19 using catalytic imidazole (0.6 equiv.), 10 equiv of Ac2O, and MeCN as solvent followed by irradiation to 70 °C for 10 min. To our dismay, compound 1 was minimally soluble in MeCN and we only obtained a mixture of partially peracetylated products in very low yields that did not go to completion even after prolonged irradiation (240 min). We optimized and translated the conditions to gram scale synthesis by using DMF as solvent, 5 equiv of imidazole, 25 equiv of Ac2O, and irradiating for 120 min to form the desired compound 3 as the sole product (Table 3). The mixture was concentrated, re-suspended in CH2Cl2, washed with aq. Na2CO3, and dried under reduced pressure to yield purified 3 (1.64 g, 98 % isolated yield). The simpler purification and avoidance of pyridine and related base catalysts more than compensates for the longer irradiation time, making this method amenable and very attractive for peracetylation of carbohydrates in multigram quantities.
Table 3.
Optimization of peracetylation using imidazole at 70 °C.
| Entry | Imidazole (Equiv.) | Reaction time (min) | Yield (% of 3) |
|---|---|---|---|
| 1 | 0.6 | 240 | 5* |
| 2 | 1.0 | 240 | 20* |
| 3 | 2.0 | 240 | 40* |
| 4 | 5.0 | 120 | 100** |
Reactions were carried out using 25 equiv Ac2O, 70°C, in DMF.
Yields estimated using TLC and ESI-MS, major products were partially acetylated compounds
confirmed by TLC, ESI-MS, and 1H NMR.
We proceeded with the synthesis of 4 by treating the solution of 3 in anhydrous MeCN with TMSOTf and irradiating the mixture to 50 °C at various reaction times. The reaction was quenched by titrating the mixture with Na2CO3 to pH = 9.0 followed by extraction with EtOAc. We obtained the oxazoline 4 in 15 min under these conditions. The preparation was scaled up using 1.0 g of 3 and gave the desired product at 60 % isolated yield that is comparable with previous synthesis of 4 using conventional conductive heating.8, 20
There is a dearth of literature on the chemical manipulations of sialic acid using microwave irradiation, 16, 17, 18 which calls for improved synthetic methodologies that take advantage of this technology. Recently, Von Itzstein and co-workers reported on a fast and convenient one-step microwave-assisted de-N-acetylation of Neu5Ac congeners using 2.0 M aqueous NaOH.18 This significantly improved method could be utilized as an alternative for the tedious, multi-step deprotection of 9 and other Neu5Ac congeners.14, 21 These findings are complementary to our current efforts in expediting access to sialic acid derivatives by microwave-assisted reactions.
In conclusion, we have developed simple, rapid, and efficient microwave-assisted protocols for the synthesis of Neu5Ac1Me (1), Neu5Acβ1,2Me2 (2), Neu5Ac1Me O-peracetate (3), and the 4,5-oxazoline derivative of Neu5Ac2en1Me O-peracetate (4). These microwave-assisted reactions expedited the syntheses of compounds 1, 2, 3 and 4 at rates that are 1- to 2-orders of magnitude faster than standard procedures. These methods use benign and readily available reagents as well as streamlined the purification of 3 through simple solvent extraction. These protocols are amenable to gram scale preparation of Neu5Ac congeners and offer convenient access to important intermediates in sialic acid chemistry and in our studies of unnatural Neu5Ac peptides.
Experimental section
Synthesis of Neu5Ac1Me (1)
Neu5Ac (1.0 g, 3.2 mmol, 1 equiv) was transferred to a thick walled microwave tube and suspended in 20 mL anhydrous MeOH (Neu5Ac conc. = 0.16 M). TFA (1.29 mmol, 0.4 equiv) was added dropwise to the stirring reaction mixture, the tube sealed, and the mixture subjected to microwave irradiation using the Biotage Initiator+ SP Wave microwave reactor for 30 min at 80 °C. The mixture was concentrated under reduced pressure to give 1 at quantitative yield.
Synthesis of Neu5Ac1Me O-peracetate (3): Route A
Compound 1 (1.0 g, 3.1 mmol, 1 equiv) was transferred to a thick walled microwave tube followed by the addition of DMAP (5.0 mol%). Pyridine (30 equiv) and Ac2O (25 equiv) were added and the tube was sealed. The reaction mixture was microwave irradiated at 70 °C for 10 min. The mixture was concentrated under reduced pressure and azeotroped with 15 mL toluene to yield an oily material that was purified by silica column chromatography using CH2Cl2/MeOH (49:1) as eluent to give 3 at 93% yield.
Synthesis of Neu5Ac1Me O-peracetate (3): Route B
Compound 1 (1.0 g, 3.1 mmol, 1 equiv) was transferred to a microwave reactor tube and dissolved in 3.9 mL DMF. Imidazole (5 equiv) was added to the stirring solution of 1 followed by the addition of Ac2O (25 equiv). The vessel was sealed and heated by microwave irradiation to 70 °C for 120 min. The reaction mixture was evaporated to dryness, resuspended in H2O, and extracted with DCM. The organic layer was washed three times with saturated Na2CO3 solution, dried over Na2SO4, and evaporated to dryness yielding purified 3 at 98 % yield.
Synthesis of 4,5-oxazoline derivative of Neu5Ac2en1Me O-peracetate (4)
To a microwave reactor tube was added compound 3 (1.0 g, 1.9 mmol, 1 equiv). The vessel was capped, evacuated, and filled with Ar. The air purging process was repeated three times followed by the addition of anhydrous MeCN (15 mL) and TMSOTf (0.7 mL, 2.1 equiv.). The mixture was irradiated at 50 °C for 15 min, cooled to 0 °C in an ice bath for 5 min, and treated with saturated solution of NaHCO3 to pH = 9. The mixture was extracted with EtOAc (3 × 25 mL), the combined organic layer washed with water, dried over MgSO4, evaporated to dryness, and purified by silica column chromatography using EtOAc as eluent to give compound 4 at 60% yield.
Supplementary Material
Figure 1.
Structure of Neu5Ac and some of its congeners.
Acknowledgments
This work was supported by Washington State University Startup Fund for J.P.S. Funding for the NMR spectrometers used in this project are acknowledged: NIH grants RR0631401 RR12948, NSF grants CHE-9115282 and DBI-9604689 and the Murdock Charitable Trust.
Footnotes
† Electronic Supplementary Information (ESI) available: [experimental details, MS, 1H NMR data]. See DOI: 10.1039/b000000x/
References
- 1.Cao H, Chen X. Chevolot Y, editor. Carbohydrate Microarrays: Methods and Protocols. 2012:31–56. [Google Scholar]
- 2.von Itzstein M, Thomson RJ. Curr. Med. Chem. 1997;4:185. [Google Scholar]
- 3.Khedri Z, Muthana MM, Li YH, Muthana SM, Yu H, Cao HZ, Chen X. Chem. Commun. 2012;48:3357. doi: 10.1039/c2cc17393j. [DOI] [PubMed] [Google Scholar]
- 4.Thomson R, von Itzstein M. In: Carbohydrate-based Drug Discovery. Wong CH, editor. Wiley-VCH; Weinheim: 2003. pp. 831–862. [Google Scholar]
- 5.Kim JH, Resende R, Wennekes T, Chen HM, Bance N, Buchini S, Watts AG, Pilling P, Streltsov VA, Petric M, Liggins R, Barrett S, McKimm-Breschkin JL, Niikura M, Withers SG. Science. 2013;340:71. doi: 10.1126/science.1232552. [DOI] [PubMed] [Google Scholar]
- 6.Von Itzstein M, Jin B, Wu WY, Chandler M. Carbohydrate Research. 1993;244:181. [Google Scholar]
- 7.Schreiner E, Zbiral E, Kleineidam RG, Schauer R. Liebigs Ann. Chem. 1991 doi: 10.1016/0008-6215(92)84150-q. [DOI] [PubMed] [Google Scholar]
- 8.Lu Y, Gervay-Hague J. Carbohydr. Res. 2007;342:1636. doi: 10.1016/j.carres.2007.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Morais GR, Oliveira RS, Falconer RA. Tetrahedron Lett. 2009;50:1642. [Google Scholar]; Kumar V, Tanenbaum SW, Flashner M. Carbohydr. Res. 1982;101:155. [Google Scholar]
- 10.Marra A, Sinay P. Carbohydr. Res. 1989;190:317. doi: 10.1016/0008-6215(89)85086-4. [DOI] [PubMed] [Google Scholar]; Yu RK, Ledeen R. J. Biol. Chem. 1969;244:1306. [PubMed] [Google Scholar]
- 11.Kuhn R, Lutz P, MacDonald DL. Chem. Ber. 1966;99:611. doi: 10.1002/cber.19660990235. [DOI] [PubMed] [Google Scholar]
- 12.Saludes JP, Ames JB, Gervay-Hague J. J. Am. Chem. Soc. 2009;131:5495. doi: 10.1021/ja808286x. [DOI] [PMC free article] [PubMed] [Google Scholar]; Horn EJ, Saludes JP, Gervay-Hague J. Carbohydr. Res. 2008;343:936. doi: 10.1016/j.carres.2008.01.033. [DOI] [PubMed] [Google Scholar]
- 13.Baumberger F, Vasella A, Schauer R. Helv. Chim. Acta. 1986;69:1927. [Google Scholar]
- 14.Saludes JP, Natarajan A, DeNardo SJ, Gervay-Hague J. Chem. Biol. Drug Des. 2010;75:455. doi: 10.1111/j.1747-0285.2010.00954.x. [DOI] [PMC free article] [PubMed] [Google Scholar]; Saludes JP, Gregar TQ, Monreal IA, Cook BM, Danan-Leon LM, Gervay-Hague J. Biopolymers. 2013;99:686. doi: 10.1002/bip.22315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kappe CO, Dallinger D. Nat. Rev. Drug Disc. 2006;5:51. doi: 10.1038/nrd1926. [DOI] [PubMed] [Google Scholar]
- 16.Chopra P, Thomson RJ, Grice ID, von Itzstein M. Tetrahedron Lett. 2012;53:6254. [Google Scholar]
- 17.Patane J, Trapani V, Villavert J, McReynolds KD. Carbohydr. Res. 2009;344:820. doi: 10.1016/j.carres.2009.01.013. [DOI] [PMC free article] [PubMed] [Google Scholar]; Sardzik R, Noble GT, Weissenborn MJ, Martin A, Webb SJ, Flitsch SL. Beilstein J. Org. Chem. 2010;6:699. doi: 10.3762/bjoc.6.81. [DOI] [PMC free article] [PubMed] [Google Scholar]; Rudrawar S, Pascolutti M, Bhatt B, Thomson RJ, Von Itzstein M. Tetrahedron Lett. 2013;54:1198. [Google Scholar]
- 18.Chopra P, Madge PD, Thomson RJ, Grice RD, Von Itzstein M. Tetrahedron Lett. 2013;54:5558. [Google Scholar]
- 19.Tiwari P, Kumar R, Maulik PR, Misra AK. Eur. J. Org. Chem. 2005:4265. [Google Scholar]
- 20.Chandler M, Bamford MJ, Conroy R, Lamont B, Patel B, Patel VK, Steeples IP, Storer R, Weir NG, Wright M, Williamson C. J. Chem. Soc. Perkin Trans. 1. 1995:1173. [Google Scholar]
- 21.Gervay J, Flaherty TM, Nguyen C. Tetrahedron Lett. 1997;38:1493. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



